Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02932384 · ClinicalTrials.gov registry record · NA
Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness
A NA study, sponsored by Charles Drew University of Medicine and Science.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT02932384: Completed NA study, sponsored by Charles Drew University of Medicine and Science.
NCT02932384 is a NA study that has completed, run by Charles Drew University of Medicine and Science. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02932384, a NA study, has completed, sponsored by Charles Drew University of Medicine and Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
The proposed research study will focus on Black men who have sex with men (BMSM) who * are HIV- or unknown status AND * have not received HIV testing in over a year or * who test irregularly (on 9/21/2016, the protocol was changed to modify the last to criteria and focus on those who have not used PrEP in the prior six months). and implement an innovative, culturally-informed, peer-based, and client-centered approach that is designed to increase their awareness of their HIV status and their timely entry into prevention (including PrEP), testing, care, and treatment services. The research design compares the effect of an incentives-only approach to one that uses incentives, along with the involvement of peer mentors to support timely entry into prevention, testing, care and treatment. This phase of the study is designed to assess peer-supported intervention group versus a passport/incentive-only control group over an 18-month period using a randomized trial approach.
Primary Outcome
--Number of participants 1) human immunodeficiency virus (HIV) tested within one and six months of their baseline; 2) newly diagnosed with HIV, and 3) obtaining testing for other STDs within six months of their baseline.
Interventions
- BEHAVIORAL Intervention-Passport and Peer Mentor
- BEHAVIORAL Control-Passport Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-04 |
| Phase | NA |
What the finished NCT02932384 record still lists
NCT02932384 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Intervention-Passport and Peer Mentor is the first listed.
NCT02932384 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02932384 about?
NCT02932384 is a clinical study titled "Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness". The proposed research study will focus on Black men who have sex with men (BMSM) who * are HIV- or unknown status AND * have not received HIV testing in over a year or * who test irregularly (on 9/21/2016, the protocol was changed to modify the last to criteria and focus on those who have not used ...
What is the current status of trial NCT02932384?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2015-08. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02932384?
The interventions under investigation include: Intervention-Passport and Peer Mentor (BEHAVIORAL), Control-Passport Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT02932384?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02932384's enrollment target sits among peer trials
105 834th of 2000 higher than 1,165 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia